カテゴリー： QYResearch, 世界, 医療/バイオ

放射線塞栓術がん治療のグローバル市場2023年：経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT）

◆英語タイトル：Global Radioembolization Cancer Treatment Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8305）◆商品コード：QYR23MA8305
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：89
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の放射線塞栓術がん治療市場について調査・分析し、世界の放射線塞栓術がん治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT））、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Terumo Corporation、Merit Medical Systems、Cook Medical、Boston Scientific Corporation、Medtronic、Stryker Corporation、Depuy Synthes (J&J)、BTG International Limitedなどが含まれています。世界の放射線塞栓術がん治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、放射線塞栓術がん治療市場規模を推定する際に考慮しました。

・放射線塞栓術がん治療市場の概要
- 放射線塞栓術がん治療のタイプ別セグメント
- 世界の放射線塞栓術がん治療市場規模：タイプ別分析（経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT））
- 放射線塞栓術がん治療の用途別セグメント
- 世界の放射線塞栓術がん治療市場規模：用途別分析（病院、クリニック、その他）
- 世界の放射線塞栓術がん治療市場規模予測（2018年-2029年）

・放射線塞栓術がん治療市場の成長トレンド
- 放射線塞栓術がん治療の地域別市場規模（2018年-2029年）
- 放射線塞栓術がん治療市場ダイナミクス
- 放射線塞栓術がん治療の業界動向
- 放射線塞栓術がん治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・タイプ別セグメント：経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT）
- 世界の放射線塞栓術がん治療のタイプ別市場規模（2018年-2023年）
- 世界の放射線塞栓術がん治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界の放射線塞栓術がん治療の用途別市場規模（2018年-2023年）
- 世界の放射線塞栓術がん治療の用途別市場規模（2024年-2029年）

・放射線塞栓術がん治療の地域別市場規模
- 北米の放射線塞栓術がん治療市場規模（2018年-2029年）
- アメリカの放射線塞栓術がん治療市場規模（2018年-2029年）
- ヨーロッパの放射線塞栓術がん治療市場規模（2018年-2029年）
- アジア太平洋の放射線塞栓術がん治療市場規模（2018年-2029年）
- 中国の放射線塞栓術がん治療市場規模（2018年-2029年）
- 日本の放射線塞栓術がん治療市場規模（2018年-2029年）
- 韓国の放射線塞栓術がん治療市場規模（2018年-2029年）
- インドの放射線塞栓術がん治療市場規模（2018年-2029年）
- オーストラリアの放射線塞栓術がん治療市場規模（2018年-2029年）
- 中南米の放射線塞栓術がん治療市場規模（2018年-2029年）
- 中東・アフリカの放射線塞栓術がん治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Terumo Corporation、Merit Medical Systems、Cook Medical、Boston Scientific Corporation、Medtronic、Stryker Corporation、Depuy Synthes (J&J)、BTG International Limited

・アナリストの観点/結論

・調査方法とデータソース

Highlights
The global Radioembolization Cancer Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Radioembolization Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Radioembolization Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Radioembolization Cancer Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Radioembolization Cancer Treatment include Terumo Corporation, Merit Medical Systems, Cook Medical, Boston Scientific Corporation, Medtronic, Stryker Corporation, Depuy Synthes (J&J) and BTG International Limited, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radioembolization Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioembolization Cancer Treatment.
The Radioembolization Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Radioembolization Cancer Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioembolization Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Terumo Corporation
Merit Medical Systems
Cook Medical
Boston Scientific Corporation
Medtronic
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited
Segment by Type
Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioembolization Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioembolization Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Transarterial Radioembolization (TARE)
1.2.3 Selective Internal Radiation Therapy (SIRT)
1.3 Market by Application
1.3.1 Global Radioembolization Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radioembolization Cancer Treatment Market Perspective (2018-2029)
2.2 Radioembolization Cancer Treatment Growth Trends by Region
2.2.1 Global Radioembolization Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radioembolization Cancer Treatment Historic Market Size by Region (2018-2023)
2.2.3 Radioembolization Cancer Treatment Forecasted Market Size by Region (2024-2029)
2.3 Radioembolization Cancer Treatment Market Dynamics
2.3.1 Radioembolization Cancer Treatment Industry Trends
2.3.2 Radioembolization Cancer Treatment Market Drivers
2.3.3 Radioembolization Cancer Treatment Market Challenges
2.3.4 Radioembolization Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioembolization Cancer Treatment Players by Revenue
3.1.1 Global Top Radioembolization Cancer Treatment Players by Revenue (2018-2023)
3.1.2 Global Radioembolization Cancer Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Radioembolization Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioembolization Cancer Treatment Revenue
3.4 Global Radioembolization Cancer Treatment Market Concentration Ratio
3.4.1 Global Radioembolization Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioembolization Cancer Treatment Revenue in 2022
3.5 Radioembolization Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Radioembolization Cancer Treatment Product Solution and Service
3.7 Date of Enter into Radioembolization Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioembolization Cancer Treatment Breakdown Data by Type
4.1 Global Radioembolization Cancer Treatment Historic Market Size by Type (2018-2023)
4.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Type (2024-2029)
5 Radioembolization Cancer Treatment Breakdown Data by Application
5.1 Global Radioembolization Cancer Treatment Historic Market Size by Application (2018-2023)
5.2 Global Radioembolization Cancer Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radioembolization Cancer Treatment Market Size (2018-2029)
6.2 North America Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radioembolization Cancer Treatment Market Size by Country (2018-2023)
6.4 North America Radioembolization Cancer Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radioembolization Cancer Treatment Market Size (2018-2029)
7.2 Europe Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radioembolization Cancer Treatment Market Size by Country (2018-2023)
7.4 Europe Radioembolization Cancer Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioembolization Cancer Treatment Market Size (2018-2029)
8.2 Asia-Pacific Radioembolization Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Radioembolization Cancer Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radioembolization Cancer Treatment Market Size (2018-2029)
9.2 Latin America Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radioembolization Cancer Treatment Market Size by Country (2018-2023)
9.4 Latin America Radioembolization Cancer Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioembolization Cancer Treatment Market Size (2018-2029)
10.2 Middle East & Africa Radioembolization Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Radioembolization Cancer Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Terumo Corporation
11.1.1 Terumo Corporation Company Detail
11.1.2 Terumo Corporation Business Overview
11.1.3 Terumo Corporation Radioembolization Cancer Treatment Introduction
11.1.4 Terumo Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.1.5 Terumo Corporation Recent Development
11.2 Merit Medical Systems
11.2.1 Merit Medical Systems Company Detail
11.2.2 Merit Medical Systems Business Overview
11.2.3 Merit Medical Systems Radioembolization Cancer Treatment Introduction
11.2.4 Merit Medical Systems Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.2.5 Merit Medical Systems Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Detail
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Radioembolization Cancer Treatment Introduction
11.3.4 Cook Medical Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.3.5 Cook Medical Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Detail
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Radioembolization Cancer Treatment Introduction
11.4.4 Boston Scientific Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Radioembolization Cancer Treatment Introduction
11.5.4 Medtronic Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.5.5 Medtronic Recent Development
11.6 Stryker Corporation
11.6.1 Stryker Corporation Company Detail
11.6.2 Stryker Corporation Business Overview
11.6.3 Stryker Corporation Radioembolization Cancer Treatment Introduction
11.6.4 Stryker Corporation Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.6.5 Stryker Corporation Recent Development
11.7 Depuy Synthes (J&J)
11.7.1 Depuy Synthes (J&J) Company Detail
11.7.2 Depuy Synthes (J&J) Business Overview
11.7.3 Depuy Synthes (J&J) Radioembolization Cancer Treatment Introduction
11.7.4 Depuy Synthes (J&J) Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.7.5 Depuy Synthes (J&J) Recent Development
11.8 BTG International Limited
11.8.1 BTG International Limited Company Detail
11.8.2 BTG International Limited Business Overview
11.8.3 BTG International Limited Radioembolization Cancer Treatment Introduction
11.8.4 BTG International Limited Revenue in Radioembolization Cancer Treatment Business (2018-2023)
11.8.5 BTG International Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 放射線塞栓術がん治療のグローバル市場2023年：経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT）(Global Radioembolization Cancer Treatment Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 前立腺がん治療装置のグローバル市場予測2023-2029
  • 骨がん治療薬の世界市場2022年～2029年：種類別、薬物種類別、流通チャネル別、地域別
  • 世界の眼がん治療市場インサイト及び予測（経口、静脈内、熱帯、その他）
  • 世界の脳がん治療市場インサイト及び予測（化学療法、免疫療法、標的療法、その他）
  • 世界の進行性甲状腺がん治療用薬市場2022年：カボザンチニブ、ソラフェニブ、バンデタニブ、レンバチニブ